Microcosm Epoch has secured millions in Pre-A financing led by Kunlun Capital to advance its quantum computing applications in the biomedical and materials sectors.

Information on the Target

Microcosm Epoch, a pioneering company in quantum computing applications, has recently announced the completion of a Pre-A round financing, raising millions of yuan. This funding round was co-led by Kunlun Capital and Hefei High-Tech Investment. Established in February 2022, Microcosm Epoch aims to address critical challenges in the national quantum computing industry by bridging gaps and advancing the application of quantum technologies in various sectors.

The company specializes in utilizing core technologies, such as quantum chemistry simulations and quantum optimization algorithms, to innovate drug discovery and new materials design. Their efforts expedite the development of new drugs and materials while optimizing associated costs and timelines. The core team, primarily comprised of graduates from the University of Science and Technology of China (USTC) Young Talents Program, brings diverse expertise in biology, chemistry, and artificial intelligence, collaborating with top domestic universities and research institutions to enhance their research and development capabilities.

Industry Overview in China

China's quantum computing industry is recognized for its rapid advancements and research output, positioning itself among global leaders. In recent years, the Chinese government has prioritized investments in quantum research, accelerating the

View Source

Similar Deals

启明创投 演生潮(北京)生物科技有限公司

2025

Pre-Seed Stage Bio Therapeutic Drugs China
Qiming Venture Partners Iongen Therapeutics Co., Ltd.

2025

Pre-Seed Stage Proprietary & Advanced Pharmaceuticals China
山蓝资本与元璟资本 益佳达医疗科技(上海)有限公司

2024

Pre-Seed Stage Medical Devices & Implants China
启明创投 演生潮

2023

Pre-Seed Stage Proprietary & Advanced Pharmaceuticals China
阳光融汇资本 宁康瑞珠生物制药(珠海)有限公司

2023

Pre-Seed Stage Proprietary & Advanced Pharmaceuticals China
启明创投 阳光安津(南京)生物医药科技有限公司

2023

Pre-Seed Stage Proprietary & Advanced Pharmaceuticals China

昆仑资本

invested in

微观纪元

in 2024

in a Pre-Seed Stage deal

Disclosed details

Transaction Size: $5M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert